Live Breaking News & Updates on Rvmd

Stay updated with breaking news from Rvmd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Insider Selling: Revolution Medicines, Inc. (NASDAQ:RVMD) CFO Sells $400,300.00 in Stock

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) CFO Jack Anders sold 10,000 shares of Revolution Medicines stock in a transaction that occurred on Friday, May 3rd. The stock was sold at an average price of $40.03, for a total value of $400,300.00. Following the completion of the transaction, the chief financial officer now directly […] ....

Jack Anders , Raymond James , Piper Sandler , Zurcher Kantonalbank Zurich Cantonalbank , Td Asset Management Inc , York Mellon Corp , Needham Company , Revolution Medicines Inc , Revolution Medicines , Get Free Report , New York Mellon Corp , Kantonalbank Zurich Cantonalbank , Management Inc , Revolution Medicines Daily , Nasdaq Rvmd , Insider Trading , Nsider Trades ,

Revolution Medicines (RVMD) Scheduled to Post Earnings on Wednesday

Revolution Medicines (NASDAQ:RVMD – Get Free Report) will be issuing its quarterly earnings data after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.75) per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link. Revolution […] ....

Piper Sandler , Raymond James , Jack Anders , Jeff Cislini , Needham Company , Revolution Medicines Inc , Revolution Medicines Company Profile , Revolution Medicines , Get Free Report , Medicines Trading Down , General Counsel Jeff Cislini , Revolution Medicines Daily , Nasdaq Rvmd ,

Revolution Medicines to Report Financial Results for First

REDWOOD CITY, Calif., May 01, 2024 (GLOBE NEWSWIRE) Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted. ....

Revolution Medicines Inc , Revolution Medicine , Nasdaq Rvmd , Revolution Medicines ,

Revolution Medicines (NASDAQ:RVMD) PT Raised to $45.00

Revolution Medicines (NASDAQ:RVMD – Get Free Report) had its target price upped by Oppenheimer from $43.00 to $45.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Oppenheimer’s price target points to a potential upside of 20.29% from the company’s current […] ....

Hong Kong , United States , Raymond James , Jack Anders , Piper Sandler , Margareta Horn , Revolution Medicines Company Profile , Shell Asset Management Co , Us Bancorp , Needham Company , Securities Exchange Commission , Hong Kong Ltd , Revolution Medicines Inc , Tower Research Capital , Revolution Medicines , Get Free Report , Exchange Commission , Kong Ltd , Asset Management , Research Capital , Revolution Medicines Daily , Nasdaq Rvmd , Boost Price Target , Oppenheimer Holdings Inc ,

Needham & Company LLC Reiterates "Buy" Rating for Revolution Medicines (NASDAQ:RVMD)

Revolution Medicines (NASDAQ:RVMD – Get Free Report)‘s stock had its “buy” rating reissued by Needham & Company LLC in a research report issued to clients and investors on Monday, Benzinga reports. They presently have a $36.00 target price on the stock. Needham & Company LLC’s target price would indicate a potential upside of 9.12% from […] ....

United States , Hong Kong , Jeff Cislini , Raymond James , Piper Sandler , Margareta Horn , Revolution Medicines Company Profile , Shell Asset Management Co , Manchester Capital Management , Needham Company , Us Bancorp , Hong Kong Ltd , Revolution Medicines Inc , Securities Exchange Commission , Revolution Medicines , Get Free Report , General Counsel Jeff Cislini , Exchange Commission , Asset Management , Kong Ltd , Revolution Medicines Daily , Nasdaq Rvmd , Reiterated Rating , Needham Company Llc ,